PRIMARY STUDY

The phytocannabinoid, Δ⁹-tetrahydrocannabivarin, can act through 5-HT₁A receptors to produce antipsychotic effects

Key Findings:  Resulting data suggests that THCV can enhance 5-HT₁A receptor activation. The authors posit that THCV may have therapeutic potential in ameliorating some of the negative, cognitive and positive symptoms associated with schizophrenia.